AndroGel Makers, Buyers Clash Over FTC Getting Discovery

By Khorri Atkinson · April 2, 2021, 10:21 PM EDT

Pharmaceutical companies scolded plaintiffs waging an antitrust fight over testosterone treatment AndroGel for asking a Pennsylvania federal court to let them share sensitive records obtained through discovery with the Federal Trade Commission....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

KING DRUG COMPANY OF FLORENCE, INC. et al v. ABBOTT LABORATORIES et al

Case Number

2:19-cv-03565

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 07, 2019